The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered in public hospitals and basic medical institutions. However, due to the growing demand ...View more details
Since China initiated 5G technology R&D and standard formulation in 2013, the landmark national-level policy has been Made in China 2025 issued by the State Council in 2015. 5G technology, along with integrated circuits ...View more details
China’s successful recovery from the COVID-19 outbreak back in mid-2020 had a positive effect on its economic performance as well as on separate sectors, including healthcare. China’s GDP managed to return to a usual pre-pandemic ...View more details
India is a world leader in the production and export of generic pharmaceuticals, accounting for approximately 20% of the global volume of generic drug sales. Despite its export markets success, India’s pharmaceuticals and healthcare ...View more details
The Philippines pharmaceuticals and healthcare sector is entering a phase of accelerated growth. The Philippines economy has grown considerably over the recent years, creating a growing middle-class population with the means to access ...View more details
The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...View more details
Indonesia’s pharmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indonesian government has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, ...View more details
Malaysia has one of the ASEAN region’s most developed pharmaceuticals and healthcare sectors. Malaysia has a two-tiered system in which the government, under the Ministry of Health, operates healthcare facilities and regulates medical practice ...View more details
Latin America was among the hardest-hit regions by the COVID-19 pandemic. The novel coronavirus entered the region at a bad time. The commodities boom at end of the 2000s combined with several local crises afterwards have hurt badly the public ...View more details
Although Thailand’s pharmaceuticals and healthcare sector has developed considerably over the past few decades, there is still considerable runway for further growth. Thailand stands out amongst emerging market countries for offering universal ...View more details